Atara Biotherapeutics (ATRA) EBT Margin Growth (1y) (2022 - 2026)
Atara Biotherapeutics (ATRA) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -84,202.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84,202.00 |
| Dec 31, 2025 | -17,360.00 |
| Sep 30, 2025 | -6,925.00 |
| Jun 30, 2025 | 8,011.00 |
| Mar 31, 2025 | 15,470.00 |
| Dec 31, 2024 | -204,675.00 |
| Sep 30, 2024 | 340,168.00 |
| Jun 30, 2024 | 4.33 Mn |
| Mar 31, 2024 | 833,979.00 |
| Dec 31, 2023 | 621,381.00 |
| Sep 30, 2023 | -157,059.00 |
| Jun 30, 2023 | -4.34 Mn |
| Dec 31, 2022 | -296,680.00 |
| Sep 30, 2022 | -30,904.00 |
| Jun 30, 2022 | 220,058.00 |